- Cohort, name
The STEPS Study (Steps to the Healthy Development and Well-being of Children)
Cohort, abbreviation
STEPS Study
Cohort, country
Finland (Suomi)
Cohort, website
https://sites.utu.fi/hyvan-kasvun-avaimet/
Key reference
Int J Epidemiol. 2013 Oct;42(5):1273-84. doi: 10.1093/ije/dys150
Date of filling in this questionnaire:
2024-10-11 - Principal investigator(s), name
Hanna Lagström
Principal investigator(s), e-mail address
hanlag@utu.fi
Principal investigator(s), institution
University of Turku, Public Health Unit and Centre fo Population Research Centre, 20014 Turun yliopisto
Contact person(s), name
Hanna Lagström
Contact person(s), e-mail address
hanlag@utu.fi
Contact person(s), institution address
University of Turku, Public Health Unit and Centre fo Population Research Centre, 20014 University of Turku
- Main aim of cohort
The overall objective is to contribute to a comprehensive, integrated view of healthy development: to improve the understanding of the early development of children, and their health and well-being beginning from the prenatal period up to school age; and also to determine the long-term effects of their early development later on in life. The STEPS Study endeavours to especially shed light on how various areas of development are interrelated during the first years of life. MAIN OUTCOMES Postnatal growth patterns, owerweigh and obesity Recurrent (respiratory) infections Asthma and allergy Chronic diseases Neurological disorders, cognition Normative picture of typical development and difficulties Mono- and bilingual development Child’s emotional and social development Child’s (early) peer relations MAIN EXPOSURES: Biological determinants - Foetal and postnatal growth characteristics - Parental anthropometrics - Genetic variants in the child and parents - Prevalence and incidence of diseases - Information from registers Psychosocial determinants - Child temperament - Relationships between the child and parent(s) - Parenting self-efficacy, maternal and paternal depression, social phobia, anxiety, loneliness, dyadic and triadic relationships Social and demographic determinants - Parental education, employment and household income - Parental marital status, etc. Environmental determinants - Parental life style habits - Housing conditions - Health and social care utilization system - Early child care contexts (home and day care)
Recruited number of:
1805 children / 1797 mothers / 1658 fathers / 0 grand parents / 0 other family members
Approximate proportion of source population included
20
Source population
Region-based - Period of enrollment
Start: 2007-09-01, End: 2010-03-31
Enrollment period
Pregnancy, week 10 to 15
Enrollment criteria, please specify
The cohort group (SFBC) consist of all children born in the Hospital District of Southwest Finland in years 2008-2010 (n=14,946) and their mothers (n=13,436). The mothers were recruited to the STEPS Study from that cohort during the first trimester of pregnancy or after delivery.
Planned age of children at end of follow-up
Life-long / unrestricted
| General information | ---------- Child age (years) at assessment ---------- | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| <1 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | >18 | |
| Home address | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||
| School address | ||||||||||||||||||||
| Birth outcomes | |
|---|---|
| Birth weight | X |
| Birth length | X |
| Gestational age at birth | X |
| Apgar score | X |
| Congenital malformations | X |
| Stillbirth (>= 22 weeks) | X |
| Child’s sex | X |
| Head circumference | X |
| Biparietal diameter | |
| Child exposures | ---------- Child age (years) at assessment ---------- | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| <1 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | >18 | |
| Breast feeding | X | X | X | |||||||||||||||||
| Diet | X | X | X | X | X | X | ||||||||||||||
| Dietary supplements | ||||||||||||||||||||
| Childcare attendance | X | X | X | X | X | X | X | |||||||||||||
| Active smoking | X | |||||||||||||||||||
| Passive smoking | X | X | X | X | ||||||||||||||||
| Alcohol consumption | ||||||||||||||||||||
| Physical activity | X | X | X | X | X | X | X | X | X | |||||||||||
| Substance use | ||||||||||||||||||||
| Medicine intake | X | X | X | X | X | X | X | X | X | |||||||||||
| Vaccinations | X | X | X | X | X | X | X | X | X | |||||||||||
| Psychological distress (e.g. bullying) | ||||||||||||||||||||
| Air pollution | ||||||||||||||||||||
| Access to green spaces | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||
| Built environment | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||
| Noise | ||||||||||||||||||||
| Radiation, electromagnetic fields | ||||||||||||||||||||
| Water contamination | ||||||||||||||||||||
| Pets | X | X | X | X | X | X | X | X | ||||||||||||
| Farm animal exposure | ||||||||||||||||||||
| Biomarkers of exposure | ||||||||||||||||||||
| Mercury | ||||||||||||||||||||
| Lead | ||||||||||||||||||||
| Cadmium | ||||||||||||||||||||
| Arsenic | ||||||||||||||||||||
| Other metals | ||||||||||||||||||||
| Polychlorinated biphenyl esters | ||||||||||||||||||||
| Dicloro difenil tricloroetano | ||||||||||||||||||||
| Hexachlorobenzene | ||||||||||||||||||||
| Brominated flame retardants | ||||||||||||||||||||
| Perflouralkyl compounds | ||||||||||||||||||||
| Bisphenol A | ||||||||||||||||||||
| Other bisphenols | ||||||||||||||||||||
| Parabens | ||||||||||||||||||||
| Benzophenones | ||||||||||||||||||||
| Triclosan | ||||||||||||||||||||
| Phthalates | ||||||||||||||||||||
| Cotinine | ||||||||||||||||||||
| Child development and health | ---------- Child age (years) at assessment ---------- | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| <1 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | >18 | |
| Anthropometry | ||||||||||||||||||||
| Weight | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||
| Height | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||
| Head circumference | X | |||||||||||||||||||
| Abdominal circumference | ||||||||||||||||||||
| Arm circumference | ||||||||||||||||||||
| Wrist circumference | ||||||||||||||||||||
| Waist circumference | X | X | X | X | ||||||||||||||||
| Clinical examinations | ||||||||||||||||||||
| Blood pressure | X | X | X | X | X | X | X | X | ||||||||||||
| Carotida intima media thickness | ||||||||||||||||||||
| Pulse wave velocity | ||||||||||||||||||||
| Cardiac ultrasound | ||||||||||||||||||||
| Renal ultrasound | ||||||||||||||||||||
| Brain MRI | ||||||||||||||||||||
| Other MRI | ||||||||||||||||||||
| DEXA‐scan results | ||||||||||||||||||||
| Skin folds | ||||||||||||||||||||
| Bio impedence | X | X | X | X | X | X | ||||||||||||||
| Oscilometry | ||||||||||||||||||||
| Spirometry | X | X | X | |||||||||||||||||
| Skin prick test | ||||||||||||||||||||
| Bronchial challenge test | ||||||||||||||||||||
| Reversibility test | ||||||||||||||||||||
| Dental observations | ||||||||||||||||||||
| Mental and neurological development | ||||||||||||||||||||
| Cognitive function | X | X | ||||||||||||||||||
| School performance | ||||||||||||||||||||
| Language | X | X | X | X | X | X | ||||||||||||||
| ADHD | ||||||||||||||||||||
| Autism | ||||||||||||||||||||
| Sleep disturbances | X | |||||||||||||||||||
| Mental health | X | X | X | X | X | X | X | X | X | |||||||||||
| Respiratory health | ||||||||||||||||||||
| Asthma | X | X | X | X | X | X | X | X | X | |||||||||||
| Allergy | X | X | X | X | X | X | X | X | X | |||||||||||
| Allergic rhinitis | X | X | X | X | X | X | X | X | X | |||||||||||
| Eczema | X | X | X | X | X | X | X | X | X | |||||||||||
| Respiratory tract infections | X | X | X | X | X | X | X | X | X | X | ||||||||||
| Senses | ||||||||||||||||||||
| Vision | ||||||||||||||||||||
| Hearing | ||||||||||||||||||||
| Musculo-skeletal health | ||||||||||||||||||||
| Back pain | ||||||||||||||||||||
| Neck pain | ||||||||||||||||||||
| Growing pains | ||||||||||||||||||||
| Sexual maturation | ||||||||||||||||||||
| Tanner stage | ||||||||||||||||||||
| Pubertal development stage | ||||||||||||||||||||
| Age at menarche | ||||||||||||||||||||
| Age at voice change | ||||||||||||||||||||
| 2D/4D digit ratio | ||||||||||||||||||||
| Nocturnal ejaculation | ||||||||||||||||||||
| Acne | ||||||||||||||||||||
| Other health outcomes | ||||||||||||||||||||
| Cancer | ||||||||||||||||||||
| Diabetes | X | X | X | X | X | |||||||||||||||
| Congenital anomalies | ||||||||||||||||||||
| Biomarkers of health | ||||||||||||||||||||
| Nephrology (e.g. creatinine, albumin) | ||||||||||||||||||||
| Thyroid hormones | ||||||||||||||||||||
| Inflammatory markers (e.g. C-reactive protein cytokines) | ||||||||||||||||||||
| Immunologic markers (e.g. immunoglobulines) | X | X | X | |||||||||||||||||
| Cortisol | ||||||||||||||||||||
| Vitamines and micronutrients | ||||||||||||||||||||
| Gonadal axis hormones (e.g. testosterone, estradiol) | ||||||||||||||||||||
| Metabolism (e.g. cholesterol, LDL, HDL, insulin, triglycerides) | ||||||||||||||||||||
| Metabolomics | ||||||||||||||||||||
| DNA methylation | ||||||||||||||||||||
| Transcriptomics (mRNA, miRNA) | ||||||||||||||||||||
| Genome-wide association study (GWAS) | ||||||||||||||||||||
| Child biological samples | ---------- Child age (years) at sampling ---------- | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| At birth | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | >18 | |
| Whole blood | X | X | X | X | X | X | X | ||||||||||||||
| Serum | X | X | X | X | X | X | X | ||||||||||||||
| Plasma | X | X | X | X | X | X | X | ||||||||||||||
| Buffy coat | X | ||||||||||||||||||||
| Urine | |||||||||||||||||||||
| Hair | X | ||||||||||||||||||||
| Teeth | |||||||||||||||||||||
| Nails | |||||||||||||||||||||
| Saliva | X | ||||||||||||||||||||
| Purified DNA | X | ||||||||||||||||||||
| Purified RNA | |||||||||||||||||||||
| Red blood cells | |||||||||||||||||||||
| Umbilical cord blood/tissue | X | ||||||||||||||||||||
| Blood smear | |||||||||||||||||||||
| Faeces/meconium | X | X | X | X | X | ||||||||||||||||
| Exhaled breathe condensate | |||||||||||||||||||||
| Sputum induction | |||||||||||||||||||||
| Placenta | |||||||||||||||||||||
| General information | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre-pregnancy | During pregnancy | <1 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | |
| Education | X | X | |||||||||||||||||||
| Income | X | X | |||||||||||||||||||
| Employment status | |||||||||||||||||||||
| Job title | |||||||||||||||||||||
| Single parenthood | X | ||||||||||||||||||||
| Home address | |||||||||||||||||||||
| Work address | |||||||||||||||||||||
| Maternal characteristics related to the index pregnancy/child | |
|---|---|
| Age at birth | X |
| Ethnicity | X |
| Country of birth | |
| Planned pregnancy | X |
| Time to pregnancy | X |
| Fertility treatment | X |
| Prior spontaneous abortion (<22w) | X |
| Prior births | X |
| Ultrasound measurements | |
| Doppler measurements | |
| Preeclampsia | |
| Gestational diabetes | |
| Gestational hypertension | |
| Gestational duration | X |
| Mode of delivery | X |
| Prenatal diagnostics | X |
| Medical termination of pregnancy | X |
| Maternal Exposures | ---------- Timing of assessment ---------- | ||||
|---|---|---|---|---|---|
| Pre-pregnancy | First trimester | Second trimester | Third trimester | Post pregnancy | |
| Diet | X | X | |||
| Dietary supplements | |||||
| Active smoking | X | X | X | ||
| Passive smoking | |||||
| Alcohol consumption | X | X | |||
| Physical activity | X | X | |||
| Substance use | X | X | |||
| Medicine intake | X | X | |||
| Coffee drinking | |||||
| Psychological distress (e.g. life-events, health behaviors, perceived stress) | X | X | |||
| Occupational exposures | |||||
| Heavy lifts | |||||
| Work hours | |||||
| Air pollution | |||||
| Access to green spaces | |||||
| Built environment | |||||
| Noise | |||||
| Radiation, electromagnetic fields | |||||
| Water contamination | |||||
| Binge drinking | X | X | |||
| Pets | |||||
| Farm animal exposure | |||||
| Biomarkers of exposure | |||||
| Mercury | |||||
| Lead | |||||
| Cadmium | |||||
| Arsenic | |||||
| Other metals | |||||
| Polychlorinated biphenyl esters | |||||
| Dicloro difenil tricloroetano | |||||
| Hexachlorobenzene | |||||
| Brominated flame retardants | |||||
| Perflouralkyl compounds | |||||
| Bisphenol A | |||||
| Other bisphenols | |||||
| Parabens | |||||
| Benzophenones | |||||
| Triclosan | |||||
| Phthalates | |||||
| Cotinine | |||||
| Maternal health | ---------- Timing of assessment ---------- | ||||
|---|---|---|---|---|---|
| Pre-pregnancy | First trimester | Second trimester | Third trimester | Post pregnancy | |
| Anthropometry | |||||
| Weight | X | X | X | X | X |
| Height | X | X | X | X | X |
| Waist circumference | |||||
| Clinical examinations | |||||
| Blood pressure | X | X | |||
| Carotida intima media thickness | |||||
| Pulse wave velocity | |||||
| DEXA scans | |||||
| Bioimpedence | |||||
| Mental and neurological development | |||||
| Mental health | X | X | |||
| Cognitive function (e.g. intelligence quotient) | |||||
| Respiratory health | |||||
| Asthma | |||||
| Allergy | |||||
| Musculo‐skeletal disease | X | X | |||
| Back pain | |||||
| Neck pain | |||||
| Arthritis | |||||
| Other health outcomes | |||||
| Cancer | X | X | |||
| Diabetes | X | X | X | ||
| Cardio‐vascular disease | X | X | |||
| Family history of chronic disease | |||||
| Infectious disease | X | X | |||
| Fever | |||||
| Autoimmune disease | X | X | |||
| Urinary symptoms | |||||
| Sexual problems | |||||
| Sleep disturbance | |||||
| Biomarkers of health | |||||
| Nephrology (e.g. creatinine, albumin) | |||||
| Thyroid hormones | |||||
| Inflammatory markers (e.g. C-reactive protein cytokines) | |||||
| Immunologic markers (e.g. immunoglobulines) | |||||
| Cortisol | |||||
| Vitamines and micronutrients | |||||
| Gonadal axis hormones (e.g. testosterone, estradiol) | |||||
| Metabolism (e.g. cholesterol, LDL, HDL, insulin, triglycerides) | |||||
| Metabolomics | |||||
| DNA methylation | |||||
| Transcriptomics (mRNA, miRNA) | |||||
| Genome-wide association study (GWAS) | |||||
| Maternal biological samples | ---------- Timing of sampling ---------- | ||||
|---|---|---|---|---|---|
| Pre-pregnancy | First trimester | Second trimester | Third trimester | Post pregnancy | |
| Breast milk | X | ||||
| Whole blood | X | ||||
| Serum | X | ||||
| Plasma | |||||
| Buffy coat | |||||
| Urine | |||||
| Hair | |||||
| Nails | |||||
| Saliva | X | ||||
| Purified DNA | X | ||||
| Purified RNA | |||||
| Red blood cells | |||||
| Faeces | |||||
| General information | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre-pregnancy | During pregnancy | <1 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | |
| Education | X | ||||||||||||||||||||
| Income | X | ||||||||||||||||||||
| Employment status | |||||||||||||||||||||
| Job title | |||||||||||||||||||||
| Single parenthood | |||||||||||||||||||||
| Home address | |||||||||||||||||||||
| Work address | |||||||||||||||||||||
| Paternal characteristics related to the index pregnancy/child | |
|---|---|
| Fertility treatment | |
| Age at child's birth | X |
| Ethnicity | X |
| Country of birth | |
| Paternal exposures | ---------- Timing of assessment ---------- | ||
|---|---|---|---|
| Pre-pregnancy | During pregnancy | Post pregnancy | |
| Diet | X | X | |
| Dietary supplements | |||
| Active smoking | X | X | |
| Passive smoking | |||
| Alcohol consumption | X | X | |
| Physical activity | X | X | |
| Substance use | X | X | |
| Medicine intake | |||
| Coffee drinking | |||
| Psychological distress (e.g. life-events, health behaviors, perceived stress) | X | X | |
| Occupational exposures | X | X | |
| Heavy lifts | |||
| Work hours | |||
| Air pollution | |||
| Access to green spaces | |||
| Built environment | |||
| Noise | |||
| Radiation, electromagnetic fields | |||
| Water contamination | |||
| Binge drinking | |||
| Pets | |||
| Farm animal exposure | |||
| Biomarkers of exposure | |||
| Mercury | |||
| Lead | |||
| Cadmium | |||
| Arsenic | |||
| Other metals | |||
| Polychlorinated biphenyl esters | |||
| Dicloro difenil tricloroetano | |||
| Hexachlorobenzene | |||
| Brominated flame retardants | |||
| Perflouralkyl compounds | |||
| Bisphenol A | |||
| Other bisphenols | |||
| Parabens | |||
| Benzophenones | |||
| Triclosan | |||
| Phthalates | |||
| Cotinine | |||
| Paternal health | ---------- Timing of assessment ---------- | ||
|---|---|---|---|
| Pre-pregnancy | During pregnancy | Post pregnancy | |
| Anthropometry | |||
| Weight | X | X | |
| Height | X | X | |
| Waist circumference | |||
| Clinical examinations | |||
| Blood pressure | X | X | |
| Carotida intima media thickness | |||
| Pulse wave velocity | |||
| DEXA scans | |||
| Bio impedence | |||
| Mental and neurological development | |||
| Mental health | X | X | |
| Cognitive function (e.g. intelligence quotient) | |||
| Respiratory health | |||
| Asthma | |||
| Allergy | |||
| Musculo‐skeletal disease | X | X | |
| Back pain | |||
| Neck pain | |||
| Arthritis | |||
| Other health outcomes | |||
| Cancer | X | X | |
| Diabetes | X | X | |
| Cardio‐vascular disease | X | X | |
| Family history of chronic disease | |||
| Infectious disease | X | X | |
| Fever | |||
| Autoimmune disease | X | X | |
| Urinary symptoms | |||
| Sexual problems | |||
| Sleep disturbance | |||
| Biomarkers of health | |||
| Nephrology (e.g. creatinine, albumin) | |||
| Thyroid hormones | |||
| Inflammatory markers (e.g. C-reactive protein cytokines) | |||
| Immunologic markers (e.g. immunoglobulines) | |||
| Cortisol | |||
| Vitamines and micronutrients | |||
| Gonadal axis hormones (e.g. testosterone, estradiol) | |||
| Metabolism (e.g. cholesterol, LDL, HDL, insulin, triglycerides) | |||
| Metabolomics | |||
| DNA methylation | |||
| Transcriptomics (mRNA, miRNA) | |||
| Genome-wide association study (GWAS) | |||
| Paternal biological samples | ---------- Timing of sampling ---------- | ||
|---|---|---|---|
| Pre-pregnancy | During pregnancy | Post pregnancy | |
| Semen | |||
| Whole blood | X | ||
| Serum | X | ||
| Plasma | |||
| Buffy coat | |||
| Urine | |||
| Hair | |||
| Nails | |||
| Saliva | X | ||
| Purified DNA | X | ||
| Purified RNA | |||
| Red blood cells | |||
| Faeces | |||
Comments and ideas
